Psychedelicnewsbreaks Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress On Ketamine NDA And HOPE Clinic Rollup April 24, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1111026582/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Reports-Q1-Results-Highlights-Progress-On-Ketamine-NDA-And-HOPE-Clinic-Rollup
